<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757561</url>
  </required_header>
  <id_info>
    <org_study_id>伦审[2012]324号</org_study_id>
    <nct_id>NCT01757561</nct_id>
  </id_info>
  <brief_title>The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane</brief_title>
  <official_title>The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose of this study is to investigate whether propofol and sevoflurane have difference
      effect on cerebral oxygenation .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the purpose of this study:(1) to investigate the incidence of preoperative cerebral
      oxygenation abnormity (SjvO2 &lt;55%) and its relationship with intraoperative cerebral
      desaturation and POCD. (2) To investigate the change of intraoperative cerebral oxygen supply
      and demand balance and the incidence of cerebral desaturation in patients with abnormal
      preoperative cerebral oxygenation during sevoflurane anesthesia. (3)To investigate the
      incidence of early POCD in patients with abnormal preoperative cerebral oxygenation during
      sevoflurane and propofol anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the Incidence of Intraoperative Desaturation Between Propofol and Sevoflurane General Anesthesia</measure>
    <time_frame>baseline ,every hour in the operation period,after extubation</time_frame>
    <description>SjvO2 were measured before anesthesia, after intubation, every hour during operation, after extubation by jugular vein blood and atrial blood gas analysis.The incidence of intraoperative cerebral desaturation was recorded when SjvO2&lt;50%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the Incidence of Postoperative Cognitive Disfunction(POCD)Between Propofol and Sevoflurane General Anesthesia</measure>
    <time_frame>1-3days、5-7days after operation</time_frame>
    <description>The incidence of early POCD was recorded. The MMSE score and the Montreal cognitive assessment (MoCA) score were recorded 1day before surgery, 1-3 day after surgery and 5-7 day after surgery. The POCD was defined as MMSE score illiterate group ≤ 17, primary and secondary school group ≤ 20, junior high school and above group ≤ 24，or the MoCA score decreased 20% with the baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Change in the Level of Serum BDNF(Brain-derived Neurotrophic Factor ) Between Propofol and Sevoflurane Anesthesia</measure>
    <time_frame>before anesthesia, after extubation ,1day after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Change in the Level of Serum s-100β Between Propofol and Sevoflurane Anesthesia</measure>
    <time_frame>before anesthesia,after extubation,1 day after operation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Vital Signs</measure>
    <time_frame>baseline , evey hour in the operation,afte extubation</time_frame>
    <description>heart rate, artery blood pressure,pulse oxygen saturation,temperature</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood Gas Analysis</measure>
    <time_frame>baseline,every hour in the operation,after extubation</time_frame>
    <description>including artery blood and blood from jugular vein bulb</description>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">144</enrollment>
  <condition>Cerebral Hypoxia</condition>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Propofol-Abnormal</arm_group_label>
    <description>patients with preoperative SjvO2&lt;55%,using the TIVA technology with propofol,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol-Normal</arm_group_label>
    <description>patients with preoperative SjvO2≥55%,using the TIVA technology with propofol,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane-Abnormal</arm_group_label>
    <description>patients with preoperative SjvO2&lt;55%,using the VIMA technology with sevoflurane,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane-Normal</arm_group_label>
    <description>patients with preoperative SjvO2≥55%,using the VIMA technology with sevoflurane,</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>use total intravenous anesthesia with propofol</description>
    <arm_group_label>Propofol-Abnormal</arm_group_label>
    <arm_group_label>Propofol-Normal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>use inhalation anesthesia with sevoflurane</description>
    <arm_group_label>Sevoflurane-Abnormal</arm_group_label>
    <arm_group_label>Sevoflurane-Normal</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing elective major surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled to take major surgery under general anesthesia over 18 years old classified
             as ASA class three or less

        Exclusion Criteria:

          -  have a diagnosis of cerebrovascular disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guo J Ying, Master</last_name>
    <role>Study Chair</role>
    <affiliation>the First Affiliated Hospital of SunYetSen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>the First Affiliated Hospital of Sun YetSen University</name>
      <address>
        <city>Guang Zhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2012</study_first_submitted>
  <study_first_submitted_qc>December 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2012</study_first_posted>
  <results_first_submitted>March 23, 2015</results_first_submitted>
  <results_first_submitted_qc>August 18, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 18, 2015</results_first_posted>
  <last_update_submitted>August 18, 2015</last_update_submitted>
  <last_update_submitted_qc>August 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Jun-ying Guo</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <keyword>jugular bulb oxygen saturation</keyword>
  <keyword>postoperative cognitive dysfunction</keyword>
  <keyword>propofol</keyword>
  <keyword>sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Propofol-Abnormal</title>
          <description>patients with preoperative SjvO2&lt;55%
propofol: use total intravenous anesthesia with propofol</description>
        </group>
        <group group_id="P2">
          <title>Propofol-Normal</title>
          <description>patients with preoperative SjvO2≥55%
propofol: use total intravenous anesthesia with propofol</description>
        </group>
        <group group_id="P3">
          <title>Sevoflurane-Abnormal</title>
          <description>patients with preoperative SjvO2&lt;55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
        </group>
        <group group_id="P4">
          <title>Sevoflurane-Normal</title>
          <description>patients with preoperative SjvO2≥55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="38"/>
                <participants group_id="P4" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Propofol-Abnormal</title>
          <description>patients with preoperative SjvO2&lt;55%
propofol: use total intravenous anesthesia with propofol</description>
        </group>
        <group group_id="B2">
          <title>Propofol-Normal</title>
          <description>patients with preoperative SjvO2≥55%
propofol: use total intravenous anesthesia with propofol</description>
        </group>
        <group group_id="B3">
          <title>Sevoflurane-Abnormal</title>
          <description>patients with preoperative SjvO2&lt;55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
        </group>
        <group group_id="B4">
          <title>Sevoflurane-Normal</title>
          <description>patients with preoperative SjvO2≥55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="31"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.5" spread="7.6"/>
                    <measurement group_id="B2" value="69" spread="10.5"/>
                    <measurement group_id="B3" value="64.2" spread="8.3"/>
                    <measurement group_id="B4" value="67.2" spread="8.5"/>
                    <measurement group_id="B5" value="65.7" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA</title>
          <description>ASA I No organic, physiologic, biochemical or psychiatric disturbance ASA II A patient with mild systemic disease that results in no functional limitation. Examples: well-controlled hypertension, uncomplicated diabetes mellitus.
ASA III A patient with severe systemic disease that results in functional impairment ASA IV Severe systemic disease that is a constant threat to life. ASA V Moribund condition in a patient who is not expected to survive with or without the operation.
ASA VI Declared brain death patient whose organs are being harvested for transplantation.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>ASAⅡ</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA Ⅲ</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>the Incidence of Intraoperative Desaturation Between Propofol and Sevoflurane General Anesthesia</title>
        <description>SjvO2 were measured before anesthesia, after intubation, every hour during operation, after extubation by jugular vein blood and atrial blood gas analysis.The incidence of intraoperative cerebral desaturation was recorded when SjvO2&lt;50%.</description>
        <time_frame>baseline ,every hour in the operation period,after extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol-Abnormal</title>
            <description>patients with preoperative SjvO2&lt;55%
propofol: use total intravenous anesthesia with propofol</description>
          </group>
          <group group_id="O2">
            <title>Propofol-Normal</title>
            <description>patients with preoperative SjvO2≥55%
propofol: use total intravenous anesthesia with propofol</description>
          </group>
          <group group_id="O3">
            <title>Sevoflurane-Abnormal</title>
            <description>patients with preoperative SjvO2&lt;55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
          </group>
          <group group_id="O4">
            <title>Sevoflurane-Normal</title>
            <description>patients with preoperative SjvO2≥55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
          </group>
        </group_list>
        <measure>
          <title>the Incidence of Intraoperative Desaturation Between Propofol and Sevoflurane General Anesthesia</title>
          <description>SjvO2 were measured before anesthesia, after intubation, every hour during operation, after extubation by jugular vein blood and atrial blood gas analysis.The incidence of intraoperative cerebral desaturation was recorded when SjvO2&lt;50%.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Incidence of Postoperative Cognitive Disfunction(POCD)Between Propofol and Sevoflurane General Anesthesia</title>
        <description>The incidence of early POCD was recorded. The MMSE score and the Montreal cognitive assessment (MoCA) score were recorded 1day before surgery, 1-3 day after surgery and 5-7 day after surgery. The POCD was defined as MMSE score illiterate group ≤ 17, primary and secondary school group ≤ 20, junior high school and above group ≤ 24，or the MoCA score decreased 20% with the baseline.</description>
        <time_frame>1-3days、5-7days after operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol-Abnormal</title>
            <description>patients with preoperative SjvO2&lt;55%
propofol: use total intravenous anesthesia with propofol</description>
          </group>
          <group group_id="O2">
            <title>Propofol-Normal</title>
            <description>patients with preoperative SjvO2≥55%
propofol: use total intravenous anesthesia with propofol</description>
          </group>
          <group group_id="O3">
            <title>Sevoflurane-Abnormal</title>
            <description>patients with preoperative SjvO2&lt;55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
          </group>
          <group group_id="O4">
            <title>Sevoflurane-Normal</title>
            <description>patients with preoperative SjvO2≥55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
          </group>
        </group_list>
        <measure>
          <title>the Incidence of Postoperative Cognitive Disfunction(POCD)Between Propofol and Sevoflurane General Anesthesia</title>
          <description>The incidence of early POCD was recorded. The MMSE score and the Montreal cognitive assessment (MoCA) score were recorded 1day before surgery, 1-3 day after surgery and 5-7 day after surgery. The POCD was defined as MMSE score illiterate group ≤ 17, primary and secondary school group ≤ 20, junior high school and above group ≤ 24，or the MoCA score decreased 20% with the baseline.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1--3days after operation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5-7 days after operation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Change in the Level of Serum BDNF(Brain-derived Neurotrophic Factor ) Between Propofol and Sevoflurane Anesthesia</title>
        <time_frame>before anesthesia, after extubation ,1day after operation</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Change in the Level of Serum s-100β Between Propofol and Sevoflurane Anesthesia</title>
        <time_frame>before anesthesia,after extubation,1 day after operation</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Vital Signs</title>
        <description>heart rate, artery blood pressure,pulse oxygen saturation,temperature</description>
        <time_frame>baseline , evey hour in the operation,afte extubation</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Blood Gas Analysis</title>
        <description>including artery blood and blood from jugular vein bulb</description>
        <time_frame>baseline,every hour in the operation,after extubation</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>the day of surgery and 1 week after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Propofol-Abnormal</title>
          <description>patients with preoperative SjvO2&lt;55%
propofol: use total intravenous anesthesia with propofol</description>
        </group>
        <group group_id="E2">
          <title>Propofol-Normal</title>
          <description>patients with preoperative SjvO2≥55%
propofol: use total intravenous anesthesia with propofol</description>
        </group>
        <group group_id="E3">
          <title>Sevoflurane-Abnormal</title>
          <description>patients with preoperative SjvO2&lt;55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
        </group>
        <group group_id="E4">
          <title>Sevoflurane-Normal</title>
          <description>patients with preoperative SjvO2≥55%
sevoflurane: use inhalation anesthesia with sevoflurane</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>heart failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>pulmonary edema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>allergy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Juan-ying Guo</name_or_title>
      <organization>FirstSunYetSen</organization>
      <phone>8602087755766(8273)</phone>
      <email>gjunying@aliyun.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

